Business
Statement re. Suspension
Beacon Rise Holdings PLC announced a proposed acquisition of Ergotec Health LLP for approximately £0.95 million, to be satisfied in cash through equity and debt financing. The company is also in preliminary discussions to acquire a UK-based educational training provider and a UK-based private chiropractor practice. Ergotec Health's unaudited accounts for the year ended March 31, 2025, show revenues of approximately £0.64 million and EBITDA of approximately £0.2 million. Trading of Beacon Rise's ordinary shares has been temporarily suspended from the Official List of the FCA and the Main Market of the London Stock Exchange. The company intends to seek admission of the enlarged share capital to trading on AIM. Disclaimer*
About this update from Beacon Rise Holdings Plc
[{"type":"text","content":"\n\nThe information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation\n \n29 September 2025\n \nBeacon Rise Holdings Plc\n(\"Beacon Rise\" or the \"Company\")\n \nProposed acquisition of Ergotec Health LLP\nPotential further acquisitions\nand\nSuspension of Listing and Share Trading\n \nBeacon Rise (LSE: BRS) is pleased to announce that it has entered non-binding heads of terms save for exclusivity and other customary terms in relation to the proposed acquisition of Ergotec Health LLP (\"Ergotec Health\") by the Company for a consideration of approximately £0.95 million (the \"Proposed Ergotec Acquisition\"). It is currently expected that the consideration payable to Chaline Tamrin Church and Colin William Church (the \"Sellers\") in respect of the Proposed Ergotec Acquisition will be satisfied in cash. The Company expects to generate the consideration payable for the Proposed Ergotec Acquisition through a combination of equity and debt financing.\n \nThe Proposed Ergotec Acquisition remains subject to a number of factors, including but not limited to, the completion of due diligence to the satisfaction of both parties, regulatory and shareholder approval, as well as the negotiation and entry into a final binding acquisition agreement (the \"Acquisition Agreement\"). Accordingly, there can be no certainty that an Acquisition Agreement will be entered into or that the Proposed Ergotec Acquisition will complete, nor or on the terms outlined in this announcement.\n \nFollowing the satisfactory completion of due diligence by both parties, execution of the Acquisition Agreement and subject to the Acquisition Agreement becoming unconditional, the Company intends to seek to cancel its ordinary shares of £1.00 each (\"Ordinary Shares\") from listing on the equity shares (shell companies) category of the Official List of the Financial Conduct Authority (the \"FCA\") and from trading on the Main Market of London Stock Exchange (\"Cancellation\"). The Company intends to contemporaneously seek admission of the enlarged share capital to trading on AIM, the London Stock Exchange's market for growth companies (\"Admission\").\n \nAllenby Capital Limited (\"Allenby Capital\") has been appointed to act as Beacon Rise'...